Surface Transforms plc (LON: SCE) announced today that the Company was notified on 5 December 2018 that Dr Kevin Johnson (CEO of Surface Transforms Plc) exercised options over 675,000 ordinary shares of 1p each in the Company.
Specifically, on 5 December 2018, Dr Kevin Johnson purchased 345,000 Ordinary Shares at a price of 9p per Ordinary Share and purchased 330,000 Ordinary Shares at a price of 11.5p.
Following the above transactions, Dr Johnson will be beneficially interested in 799,000 Ordinary Shares, which equates to approximately 0.6 per cent. of the Company’s total issued share capital.
Dr Johnson has advised that he intends to transfer all of these shares to his SIPP but this will not change his beneficial interest in the Company.
Admission and Total Voting Rights
The new Ordinary Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares of the Company. Application will be made for the 675,000 new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence at 8.00 a.m. on 11 December 2018. Following Admission, the total number of voting rights in the Company will be 123,710,416 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.